CompletedPhase 2

Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients

Iran60 participantsStarted 2023-12-04

Plain-language summary

1. Investigating its effectiveness in removing bacteria in invivo conditions 2. Investigating the effectiveness in improving the clinical symptoms of patients

Who can participate

Age range18 Years – 78 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with gastritis or stomach ulcers whose Helicobacter infection has been confirmed by a doctor and age group 18 to 78 years, all genders, if accepted Exclusion Criteria: * Acute perforation of esophagus, stomach and duodenum Hyperlipidemic people Those who are allergic to egg proteins Patients with stomach cancer

What they're measuring

Respiratory urea level (UBT) higher than cut off 50

Timeframe: Determination of respiratory urea (UBT) at the beginning of the study and 8 weeks after the start of the intervention

Trial details

NCT IDNCT06973889

SponsorMashhad University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-30

View on ClinicalTrials.gov More HELICOBACTER PYLORI INFECTIONS trials